nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti–Tumor Necrosis Factor-α Monotherapy Versus Combination Therapy with an Immunomodulator in IBD
|
Dulai, Parambir S. |
|
2014 |
43 |
3 |
p. 441-456 16 p. |
artikel |
2 |
An Update on Anti-TNF Agents in Ulcerative Colitis
|
Samaan, Mark A. |
|
2014 |
43 |
3 |
p. 479-494 16 p. |
artikel |
3 |
Biologics of IBD
|
Falk, Gary W. |
|
2014 |
43 |
3 |
p. xiii- 1 p. |
artikel |
4 |
Biologic Therapy in Inflammatory Bowel Disease
|
Loftus Jr, Edward V. |
|
2014 |
43 |
3 |
p. xv-xvii nvt p. |
artikel |
5 |
Contents
|
|
|
2014 |
43 |
3 |
p. vii-x nvt p. |
artikel |
6 |
Contributors
|
|
|
2014 |
43 |
3 |
p. iii-v nvt p. |
artikel |
7 |
Forthcoming Issues
|
|
|
2014 |
43 |
3 |
p. xi- 1 p. |
artikel |
8 |
Immunology of Inflammatory Bowel Disease and Molecular Targets for Biologics
|
Dave, Maneesh |
|
2014 |
43 |
3 |
p. 405-424 20 p. |
artikel |
9 |
Index
|
|
|
2014 |
43 |
3 |
p. 631-642 12 p. |
artikel |
10 |
Lymphocyte Homing Antagonists in the Treatment of Inflammatory Bowel Diseases
|
Saruta, Masayuki |
|
2014 |
43 |
3 |
p. 581-601 21 p. |
artikel |
11 |
Miscellaneous Adverse Events with Biologic Agents (Excludes Infection and Malignancy)
|
Feuerstein, Joseph D. |
|
2014 |
43 |
3 |
p. 543-563 21 p. |
artikel |
12 |
Pharmacokinetics of Biologics and the Role of Therapeutic Monitoring
|
Lin, Kirk |
|
2014 |
43 |
3 |
p. 565-579 15 p. |
artikel |
13 |
Risk of Infections with Biological Agents
|
Kopylov, Uri |
|
2014 |
43 |
3 |
p. 509-524 16 p. |
artikel |
14 |
The Risk of Malignancy Associated with the Use of Biological Agents in Patients with Inflammatory Bowel Disease
|
Dulai, Parambir S. |
|
2014 |
43 |
3 |
p. 525-541 17 p. |
artikel |
15 |
The Use of Biologic Agents in Pregnancy and Breastfeeding
|
Horst, Sara |
|
2014 |
43 |
3 |
p. 495-508 14 p. |
artikel |
16 |
Update on Anti-Tumor Necrosis Factor Agents in Crohn Disease
|
Singh, Siddharth |
|
2014 |
43 |
3 |
p. 457-478 22 p. |
artikel |
17 |
Update on Janus Kinase Antagonists in Inflammatory Bowel Disease
|
Boland, Brigid S. |
|
2014 |
43 |
3 |
p. 603-617 15 p. |
artikel |
18 |
Update on Ustekinumab for the Treatment of Crohn's Disease
|
Leung, Yvette |
|
2014 |
43 |
3 |
p. 619-630 12 p. |
artikel |
19 |
Who Should Receive Biologic Therapy for IBD?
|
Jones, Jennifer |
|
2014 |
43 |
3 |
p. 425-440 16 p. |
artikel |